Financhill
Back

UroGen Pharma Quote, Financials, Valuation and Earnings

UroGen Pharma Price Quote

$13.95
-0.09 (-0.64%)
(Updated: April 30, 2024 at 12:00 PM ET)

UroGen Pharma Key Stats

Buy
53
UroGen Pharma (URGN) is a Buy

Day range:
$13.92 - $14.68
52-week range:
$8.69 - $24.13
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.89
P/B ratio:
0%

Volume:
198.4K
Avg. volume:
378.1K
1-year change:
21.14%
Market cap:
$479.1M
Revenue:
$82.7M
EPS:
$-3.67

How Much Does UroGen Pharma Make?

Is UroGen Pharma Growing As A Company?

  • What Is UroGen Pharma's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.3%
  • What Is UroGen Pharma's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

UroGen Pharma Stock Price Performance

  • Did UroGen Pharma Stock Go Up Last Month?
    UroGen Pharma share price went down by -6.4% last month
  • Did URGN's Share Price Rise Over The Last Year?
    URGN share price rose by 21.14% over the past 1 year

What Is UroGen Pharma 52-Week High & Low?

UroGen Pharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy UroGen Pharma?

  • How Much Debt Does UroGen Pharma Have?
    Total long term debt quarterly is $98.6M
  • How Much Cash Does UroGen Pharma Have?
    Cash and short term investments quarterly total is $137M
  • What Is UroGen Pharma’s Book Value Per Share?
    Book value per share is -2.01

Is UroGen Pharma Cash Flow Positive?

  • What Is URGN Cash Flow From Operations?
    Cash flow from operations (TTM) is -$76.4M
  • What Is UroGen Pharma’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $116.9M
  • What Is UroGen Pharma’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$953K

UroGen Pharma Return On Invested Capital

  • Is Management Doing A Good Job?
    URGN return on invested capital is -1301.18%
  • What Is UroGen Pharma Return On Assets?
    ROA measures how assets are converting to revenues and is -71.41%
  • What Is URGN Return On Equity?
    ROE is a measure of profitability and is 0%

UroGen Pharma Earnings Date & Stock Price

UroGen Pharma Competitors

  • Who Are UroGen Pharma's Competitors?
    Below is a list of companies who compete with UroGen Pharma or are related in some way:
    • Agenus Inc (AGEN)
    • Exelixis Inc (EXEL)
    • Geron Corp (GERN)
    • InfuSystems Holdings Inc (INFU)
    • Protalix BioTherapeutics Inc (PLX)

UroGen Pharma Dividend Yield

Data Unavailable

UroGen Pharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -5.88%
Revenue: 30.06% 4.26%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 38.50
Upside from Last Price: 174.22%

Major Shareholders

  • How many URGN shares are owned by institutional investors?
    2.1M URGN shares are owned by institutional investors
  • How many URGN shares are owned by insiders?
    1M URGN shares are owned by insiders